
York Space Systems' 96% revenue from the SDA creates binary risk as the agency is absorbed. Without contract reaffirmation, the downside is severe.
York Space Systems Inc. currently carries an Alpha Score of n/a, giving AlphaScala's model a neutral read on the setup.
York Space Systems (YSS) generated 96% of its revenue from the Space Development Agency in 2025, according to its 10-K filing. That single customer is now being absorbed into a larger agency. For a company built on one government contract, the restructuring introduces a risk that cannot be hedged with a diversified portfolio. The question is not whether YSS will lose the contract tomorrow. The question is whether the absorption changes the terms, timeline, or renewal probability.
The 10-K filing makes the dependency explicit. Nearly all of YSS's top line comes from the SDA. That is not unusual for early-stage defense contractors. The structure creates a binary outcome. If the SDA's absorption into a larger agency leads to contract re-evaluation, budget reallocation, or a shift in procurement priorities, YSS has no second customer to absorb the gap. The company's valuation already reflects a growth premium tied to SDA program continuity. Any disruption would force a re-rating.
Government agency mergers rarely leave existing contracts untouched. The absorbing agency may review all active agreements for alignment with its own mandate. Even if the contract survives, the payment cycle, reporting requirements, and point of contact change. For a company with no revenue buffer, a six-month delay in contract renewal or a 10% budget cut would hit cash flow directly. The market has not yet priced this risk because the absorption process is still unfolding. YSS shares trade on the assumption that the SDA's work continues under new management. That assumption is unverified.
The risk would shrink if the absorbing agency explicitly reaffirms the YSS contract within the next quarter. A public statement from the agency or a filing from YSS confirming no change in scope or payment terms would remove the uncertainty. Another reduction factor would be YSS announcing a second customer, even a small one. A 5% revenue diversification would signal that the company can win business outside the next contract. Without either event, the concentration risk remains the dominant variable.
The risk escalates if the absorption triggers a competitive re-bid for the SDA's existing contracts. YSS would then face larger defense primes with deeper relationships to the new agency. A budget cut to the SDA's successor program would also worsen the outlook. The worst case is a contract termination without a transition plan. YSS would then need to raise capital at distressed terms or sell assets. The stock would likely trade below book value in that scenario.
The next decision point is the next quarterly filing or any 8-K disclosure about the SDA absorption. Until YSS provides clarity on contract status, the single-customer risk is the only growing. For traders, this is a watchlist item, not a position. For investors, the asymmetry is clear: the upside from a reaffirmation is limited, while the downside from a disruption is severe. The market is telling you something. It is not yet telling you the outcome.
For broader context on single-stock concentration risk, see our stock market analysis.
Prepared with AlphaScala research tooling and grounded in primary market data: live prices, fundamentals, SEC filings, hedge-fund holdings, and insider activity. Each story is checked against AlphaScala publishing rules before release. Educational coverage, not personalized advice.